Benuvia Therapeutics

Benuvia Therapeutics focuses on financing and developing low-risk assets with high clinical value to improve the quality of life for patients suffering from rare and underserved diseases. Benuvia sells SYNDROS® (our FDA-approved cannabinoid medication), and through our affiliated company, Benuvia Manufacturing, we possess state-of-the-art R&D and cGMP manufacturing facilities.